Norbert Heinrich

3.5k total citations
63 papers, 1.6k citations indexed

About

Norbert Heinrich is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Norbert Heinrich has authored 63 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 35 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Norbert Heinrich's work include Tuberculosis Research and Epidemiology (45 papers), Mycobacterium research and diagnosis (22 papers) and Pneumonia and Respiratory Infections (15 papers). Norbert Heinrich is often cited by papers focused on Tuberculosis Research and Epidemiology (45 papers), Mycobacterium research and diagnosis (22 papers) and Pneumonia and Respiratory Infections (15 papers). Norbert Heinrich collaborates with scholars based in Germany, United Kingdom and Tanzania. Norbert Heinrich's co-authors include Michael Höelscher, Andrea Rachow, Stephen H. Gillespie, Martin J. Boeree, Elmar Saathoff, Patrick Phillips, Elias N. Ntinginya, Bariki Mtafya, Andreas H. Diacon and Rodney Dawson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Norbert Heinrich

57 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norbert Heinrich Germany 23 1.3k 889 457 179 138 63 1.6k
Ida Parwati Indonesia 21 1.2k 0.9× 1.0k 1.1× 625 1.4× 176 1.0× 228 1.7× 110 1.7k
Debra Benator United States 21 1.5k 1.1× 1.3k 1.5× 649 1.4× 131 0.7× 89 0.6× 59 2.1k
Johannes Nemeth Switzerland 19 782 0.6× 586 0.7× 350 0.8× 229 1.3× 204 1.5× 61 1.5k
Sayera Banu Bangladesh 28 1.9k 1.4× 1.4k 1.6× 650 1.4× 289 1.6× 96 0.7× 117 2.4k
Erik Sturegård Sweden 21 728 0.5× 710 0.8× 467 1.0× 177 1.0× 67 0.5× 51 1.2k
Emanuele Pontali Italy 25 1.1k 0.8× 744 0.8× 237 0.5× 193 1.1× 53 0.4× 81 1.6k
Lorna Bozeman United States 18 2.0k 1.5× 1.7k 1.9× 903 2.0× 194 1.1× 54 0.4× 26 2.4k
Nyanda Elias Ntinginya Tanzania 16 754 0.6× 576 0.6× 226 0.5× 157 0.9× 80 0.6× 79 1.1k
Tine De Marez United States 12 1.2k 0.9× 869 1.0× 345 0.8× 321 1.8× 26 0.2× 17 1.6k
José A. Caminero Spain 25 1.9k 1.4× 1.5k 1.7× 960 2.1× 306 1.7× 54 0.4× 91 2.5k

Countries citing papers authored by Norbert Heinrich

Since Specialization
Citations

This map shows the geographic impact of Norbert Heinrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Heinrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Heinrich more than expected).

Fields of papers citing papers by Norbert Heinrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Heinrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Heinrich. The network helps show where Norbert Heinrich may publish in the future.

Co-authorship network of co-authors of Norbert Heinrich

This figure shows the co-authorship network connecting the top 25 collaborators of Norbert Heinrich. A scholar is included among the top collaborators of Norbert Heinrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norbert Heinrich. Norbert Heinrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charalambous, Salome, Norbert Heinrich, Elin M. Svensson, et al.. (2025). Neuromyelitis optica causing vision loss during TB treatment with sutezolid: evidence of aberrant immunity following infection. PubMed. 2(5). 306–309.
2.
Heinrich, Norbert, Veronique de Jager, Patrick Phillips, et al.. (2025). Population pharmacokinetics and exposure–response relationship of the antituberculosis drug BTZ-043. Journal of Antimicrobial Chemotherapy. 80(5). 1315–1323. 1 indexed citations
3.
Gillespie, Stephen H., Andrew R. DiNardo, Sophia B. Georghiou, et al.. (2024). Developing biomarker assays to accelerate tuberculosis drug development: defining target product profiles. The Lancet Microbe. 5(9). 100869–100869. 3 indexed citations
4.
Walter, Kerstin, Lindsey H. M. te Brake, Michael Höelscher, et al.. (2024). Investigating the treatment shortening potential of a combination of bedaquiline, delamanid and moxifloxacin with and without sutezolid, in a murine tuberculosis model with confirmed drug exposures. Journal of Antimicrobial Chemotherapy. 79(10). 2607–2610. 1 indexed citations
5.
Saluzzo, Francesca, Juan Espinosa‐Pereiro, Stephan Dressler, et al.. (2023). Community engagement in tuberculosis research: the EU-Patient-cEntric clinicAl tRial pLatforms (EU-PEARL) experience. International Journal of Infectious Diseases. 130. S20–S24. 7 indexed citations
6.
Heyckendorf, Jan, Sophia B. Georghiou, Nicole Frahm, et al.. (2022). Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies. Clinical Microbiology Reviews. 35(3). 44 indexed citations
7.
8.
Olbrich, Laura, et al.. (2022). FujiLAM for the diagnosis of childhood tuberculosis: a systematic review. BMJ Paediatrics Open. 6(1). e001447–e001447. 4 indexed citations
9.
Savić, Radojka M., Martin J. Boeree, Charles A. Peloquin, et al.. (2021). Optimising pyrazinamide for the treatment of tuberculosis. European Respiratory Journal. 58(1). 2002013–2002013. 23 indexed citations
10.
Beutler, Markus, Sara Plesnik, Norbert Heinrich, et al.. (2020). A pre-clinical validation plan to evaluate analytical sensitivities of molecular diagnostics such as BD MAX MDR-TB, Xpert MTB/Rif Ultra and FluoroType MTB. PLoS ONE. 15(1). e0227215–e0227215. 13 indexed citations
11.
Rachow, Andrea, Elmar Saathoff, Bariki Mtafya, et al.. (2018). The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay. Tuberculosis. 110. 56–58. 3 indexed citations
12.
Heinrich, Norbert, et al.. (2018). Seroepidemiological and molecular investigations of infections with Crimean–Congo haemorrhagic fever virus in Kazakhstan. International Journal of Infectious Diseases. 78. 121–127. 26 indexed citations
13.
Dittrich, Sabine, Birkneh Tilahun Tadesse, Francis Moussy, et al.. (2017). Target Product Profile for a Diagnostic Assay to Differentiate Between Bacterial and Non-Bacterial Infections to Guide Antimicrobials Use in Resource-Limited Settings: An Expert Consensus. American Journal of Tropical Medicine and Hygiene. 95. 527–527. 1 indexed citations
14.
15.
Froeschl, Guenter, Nyanda Elias Ntinginya, Chacha Mangu, et al.. (2016). Integrating Local, National, and International Stakeholders in Outbreak Preparedness in Developing Countries: Conclusions from a Conference in Mbeya, Tanzania. Health Security. 14(1). 29–34. 1 indexed citations
16.
Egere, Uzochukwu, Abdou K. Sillah, Toyin Togun, et al.. (2016). Isoniazid preventive treatment among child contacts of adults with smear-positive tuberculosis in The Gambia. Public Health Action. 6(4). 226–231. 32 indexed citations
17.
Boeree, Martin J., Andreas H. Diacon, Rodney Dawson, et al.. (2015). A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 191(9). 1058–1065. 213 indexed citations
18.
Miotto, Paolo, Grace Mwangoka, Giovanni Sotgiu, et al.. (2013). miRNA Signatures in Sera of Patients with Active Pulmonary Tuberculosis. PLoS ONE. 8(11). e80149–e80149. 72 indexed citations
19.
Rachow, Andrea, Petra Clowes, Elmar Saathoff, et al.. (2012). Increased and Expedited Case Detection by Xpert MTB/RIF Assay in Childhood Tuberculosis: A Prospective Cohort Study. Clinical Infectious Diseases. 54(10). 1388–1396. 121 indexed citations
20.
Rachow, Andrea, Alimuddin Zumla, Norbert Heinrich, et al.. (2011). Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study. PLoS ONE. 6(6). e20458–e20458. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ida Parwati Breakdown of academic impact, for papers by Debra Benator Breakdown of academic impact, for papers by Johannes Nemeth Breakdown of academic impact, for papers by Sayera Banu Breakdown of academic impact, for papers by Erik Sturegård Breakdown of academic impact, for papers by Emanuele Pontali Breakdown of academic impact, for papers by Lorna Bozeman Breakdown of academic impact, for papers by Nyanda Elias Ntinginya Breakdown of academic impact, for papers by Tine De Marez Breakdown of academic impact, for papers by José A. Caminero
Rankless by CCL
2026